Erratum to: 'Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial'

Affiliations

• ¹ Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. t.p.hellyer@ncl.ac.uk.
• ² Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.
• ³ Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
• ⁴ Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre & Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK.
• ⁵ Becton Dickinson Biosciences, Erembodegem, Aalst, Belgium.
• ⁶ Intensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK.
• ⁷ Department of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK.
• ⁸ Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK.
• ⁹ Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
• ¹⁰ Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK.
• ¹¹ MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
• ¹² University of Warwick and Heart of England NHS Foundation Trust, Coventry, UK.
• ¹³ Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
• ¹⁴ Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.
• ¹⁵ Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.